- Home
- OCUP vs TCBS Comparison
OCUP vs TCBS Comparison
Compare OCUP & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUP
- TCBS
- Stock Information
- Founded
- OCUP 2018
- TCBS 1934
- Country
- OCUP United States
- TCBS United States
- Employees
- OCUP N/A
- TCBS N/A
- Industry
- OCUP Biotechnology: Pharmaceutical Preparations
- TCBS Banks
- Sector
- OCUP Health Care
- TCBS Finance
- Exchange
- OCUP Nasdaq
- TCBS Nasdaq
- Market Cap
- OCUP 53.1M
- TCBS 46.6M
- IPO Year
- OCUP N/A
- TCBS N/A
- Fundamental
- Price
- OCUP $1.32
- TCBS $14.88
- Analyst Decision
- OCUP Strong Buy
- TCBS
- Analyst Count
- OCUP 3
- TCBS 0
- Target Price
- OCUP $18.67
- TCBS N/A
- AVG Volume (30 Days)
- OCUP 85.2K
- TCBS 1.8K
- Earning Date
- OCUP 11-11-2024
- TCBS 11-20-2024
- Dividend Yield
- OCUP N/A
- TCBS 1.08%
- EPS Growth
- OCUP N/A
- TCBS N/A
- EPS
- OCUP N/A
- TCBS N/A
- Revenue
- OCUP $16,449,000.00
- TCBS $9,785,000.00
- Revenue This Year
- OCUP N/A
- TCBS N/A
- Revenue Next Year
- OCUP $258.69
- TCBS N/A
- P/E Ratio
- OCUP N/A
- TCBS N/A
- Revenue Growth
- OCUP N/A
- TCBS N/A
- 52 Week Low
- OCUP $1.15
- TCBS $11.78
- 52 Week High
- OCUP $3.53
- TCBS $15.24
- Technical
- Relative Strength Index (RSI)
- OCUP 48.70
- TCBS 64.54
- Support Level
- OCUP $1.25
- TCBS $14.75
- Resistance Level
- OCUP $1.35
- TCBS $14.80
- Average True Range (ATR)
- OCUP 0.08
- TCBS 0.10
- MACD
- OCUP 0.01
- TCBS -0.01
- Stochastic Oscillator
- OCUP 29.17
- TCBS 80.74
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.